PFE - Pfizer Duchenne muscular dystrophy gene therapy fails in phase 3
2024-06-12 17:02:28 ET
More on Pfizer
- Pfizer: Surging Cancer Rates Will Boost Revenues
- Pfizer: Too Early For A Turnaround
- Pfizer, Flagship to collaborate on obesity drug discovery
- Pfizer Inc. (PFE) CEO Albert Bourla presents at Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
- GSK, Pfizer to appeal Delaware ruling that allowed trials for thousands of Zantac cases